MISSOURI — $110 million verdict against talc defendants Johnson and Johnson and Imerys Talc North America was overturned by a Missouri appellate court this week. The plaintiff Lois Slemp filed suit against the defendants alleging that she developed ovarian cancer as a result of her use of Johnson and Johnson’s talcum powder products for over 40 years. The trial court found personal jurisdiction based on evidence that a Missouri-based company was used to “manufacture, mislabel and package” the products. Applying the Bristol Myers Squibb decision on personal jurisdiction, the court found that the trial court lacked personal jurisdiction over the defendants because the products Slemp used were made in Georgia and bought in Virginia. Moreover, Slemp herself was not a resident of Missouri.